Showing results (181-190 of 466) with videos related to
Sort By:
Pageof 47
Journal of the American Chemical Society|December 5, 2003
Mechanism of the glutathione transferase-catalyzed conversion of antitumor 2-crotonyloxymethyl-2-cycloalkenones to GSH adductsDiana S Hamilton, Xiyun Zhang, Zhebo Ding, et al.Oncogene|April 6, 2025
Dichotomous roles of ACBD3 in NSCLC growth and metastasisXiaochao Tan, Chao Wu, Priyam Banerjee, et al.The Prostate|October 6, 2020
Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistanceYi Ding, MinJae Lee, Yan Gao, et al.Plos One|June 27, 2014
miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancerOmer Faruk Karatas, Esra Guzel, Ilknur Suer, et al.Science Advances|November 12, 2021
MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockadeQinbo Cai, Wolong Zhou, Wei Wang, et al.Cancer Research|December 13, 2017
Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast CancerLamiaa El-Shennawy, Oleksii Dubrovskyi, Irida Kastrati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosisChad J Creighton, Angelo Casa, ZaWaunyka Lazard, et al.Cancer Research|February 5, 2008
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionSuleiman Massarweh, C Kent Osborne, Chad J Creighton, et al.Endocrinology|August 9, 2008
Transcriptional response of the murine mammary gland to acute progesterone exposureRodrigo Fernandez-Valdivia, Atish Mukherjee, Chad J Creighton, et al.Cancer Chemotherapy and Pharmacology|September 6, 2000
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase IE M Sharkey, H B O'Neill, M J Kavarana, et al.Pageof 47